-transparent.png){kind=logo}
MicroRNAs are small nonprotein-coding RNAs that regulate the expressions of a wide variety of genes by sequence-specific base pairing on the 3'UTR of mRNA targets resulting in mRNA degradation or inhibition of translation. Aberrant expressions of miRNAs have been linked to tumor development, metastasis, diagnosis, prognosis, and therapy response in human breast cancer. Some miRNAs have been considered to have potential clinical applications as a tool for breast cancer prognosis and therapy. Here we describe and discuss lines of evidence supporting the important relationship between miRNAs and breast cancer, and its therapeutic strategies.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
January 2021,
Frontiers in molecular biosciences,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
February 2018,
International journal of molecular sciences,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
May 2022,
Drug delivery and translational research,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
January 2015,
Theranostics,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
April 2024,
Advanced biology,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
January 2017,
Anti-cancer agents in medicinal chemistry,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
March 2011,
Expert opinion on therapeutic targets,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
December 2010,
Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
October 2010,
Expert opinion on therapeutic targets,
Enders K O Ng, and
Chris L P Wong, and
Edmond S K Ma, and
Ava Kwong
April 2011,
Translational research : the journal of laboratory and clinical medicine,
